Goran Micevic

3.5k total citations · 1 hit paper
32 papers, 2.0k citations indexed

About

Goran Micevic is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Goran Micevic has authored 32 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Oncology and 11 papers in Immunology. Recurrent topics in Goran Micevic's work include Epigenetics and DNA Methylation (8 papers), Immunotherapy and Immune Responses (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Goran Micevic is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Immunotherapy and Immune Responses (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Goran Micevic collaborates with scholars based in United States, Australia and Canada. Goran Micevic's co-authors include Marcus Bosenberg, Nicholas Theodosakis, Katrina Meeth, William Damsky, José C. Perales, Steven H. Kleinstein, Ping‐Chih Ho, Xiaojing Liu, Matthew Staron and Robert A. Amezquita and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Goran Micevic

29 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses

2015 1.1k citations Ping‐Chih Ho, Jessica Bihuniak et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Goran Micevic United States	16	1.0k	974	796	588	129	32	2.0k
Senlin Xu China	20	1.1k 1.1×	456 0.5×	858 1.1×	610 1.0×	165 1.3×	43	2.0k
Alison M. Michie United Kingdom	27	1.2k 1.2×	1.0k 1.1×	486 0.6×	304 0.5×	98 0.8×	67	2.5k
Huiyin Lan China	11	931 0.9×	608 0.6×	508 0.6×	529 0.9×	141 1.1×	18	1.7k
Tim Hon Man Chan United States	31	1.8k 1.7×	648 0.7×	647 0.8×	489 0.8×	137 1.1×	66	2.7k
Srinivas Malladi United States	12	981 0.9×	576 0.6×	952 1.2×	384 0.7×	211 1.6×	28	1.9k
Dayana B. Rivadeneira United States	17	1.1k 1.0×	802 0.8×	957 1.2×	714 1.2×	271 2.1×	26	2.3k
Jianhua Ling United States	22	1.2k 1.1×	402 0.4×	594 0.7×	457 0.8×	86 0.7×	28	1.8k
Brian C. Grabiner United States	11	1.1k 1.1×	422 0.4×	441 0.6×	472 0.8×	164 1.3×	11	1.8k
Meixiang Sang China	27	1.7k 1.6×	557 0.6×	708 0.9×	970 1.6×	232 1.8×	107	2.4k

Countries citing papers authored by Goran Micevic

Since Specialization

Citations

This map shows the geographic impact of Goran Micevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goran Micevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goran Micevic more than expected).

Fields of papers citing papers by Goran Micevic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Goran Micevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goran Micevic. The network helps show where Goran Micevic may publish in the future.

Co-authorship network of co-authors of Goran Micevic

This figure shows the co-authorship network connecting the top 25 collaborators of Goran Micevic. A scholar is included among the top collaborators of Goran Micevic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Goran Micevic. Goran Micevic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Flem‐Karlsen, Karine, Ronan Talty, Meaghan K. McGeary, et al.. (2025). Cytotoxic CD8+ T Cells Downregulate GPX4 to Promote Ferroptosis in Melanoma That Drives Antitumor Immunity. Cancer Research. 85(21). 4139–4150.

Qin, Tingting, Austin K. Mattox, Jean S. Campbell, et al.. (2025). Epigenetic therapy sensitizes anti–PD-1 refractory head and neck cancers to immunotherapy rechallenge. Journal of Clinical Investigation. 135(6). 5 indexed citations

Eisenstein, Anna, et al.. (2025). EGFR-STAT1 pathway drives fibrosis initiation in fibroinflammatory skin diseases. Nature Communications. 16(1). 8969–8969. 1 indexed citations

Deshmukh, M.G., et al.. (2025). DNA methylation in melanoma immunotherapy: mechanisms and therapeutic opportunities. Clinical Epigenetics. 17(1). 71–71. 3 indexed citations

McGeary, Meaghan K., William Damsky, Sabine M. Lang, et al.. (2024). Setdb1 Loss Induces Type I Interferons and Immune Clearance of Melanoma. Cancer Immunology Research. 13(2). 245–257. 4 indexed citations

Roy, Simon F., et al.. (2024). Tumour necrosis is a valuable histopathological prognostic parameter in melanomas of the vulva and vagina. Pathology. 56(6). 854–864.

Micevic, Goran, Andrew Daniels, Karine Flem‐Karlsen, et al.. (2023). IL-7R licenses a population of epigenetically poised memory CD8 ⁺ T cells with superior antitumor efficacy that are critical for melanoma memory. Proceedings of the National Academy of Sciences. 120(30). e2304319120–e2304319120. 16 indexed citations

Micevic, Goran, Marcus Bosenberg, & Qin Yan. (2022). The Crossroads of Cancer Epigenetics and Immune Checkpoint Therapy. Clinical Cancer Research. 29(7). 1173–1182. 40 indexed citations

Talty, Ronan, Goran Micevic, Alice Wang, Christine J. Ko, & William Damsky. (2022). Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist. Case Reports in Dermatology. 14(2). 214–218. 1 indexed citations

10.

Talty, Ronan, Goran Micevic, William Damsky, & Brett King. (2022). Erythrodermic scabies in an immunocompetent patient. JAAD Case Reports. 29. 112–115.

11.

Newton, Ana S., John C. Faver, Goran Micevic, et al.. (2020). Structure-Guided Identification of DNMT3B Inhibitors. ACS Medicinal Chemistry Letters. 11(5). 971–976. 17 indexed citations

12.

Micevic, Goran, Durga Thakral, Meaghan K. McGeary, & Marcus Bosenberg. (2018). PD‐L1 methylation regulates PD‐L1 expression and is associated with melanoma survival. Pigment Cell & Melanoma Research. 32(3). 435–440. 62 indexed citations

13.

Micevic, Goran, et al.. (2017). Balanitis associated with FOLFIRI chemotherapy. JAAD Case Reports. 4(1). 58–60. 2 indexed citations

14.

Micevic, Goran, Nicholas Theodosakis, & Marcus Bosenberg. (2017). Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities. Clinical Epigenetics. 9(1). 34–34. 135 indexed citations

15.

Brooks, Eric D., Jonathan E. Schoenhals, Chad Tang, et al.. (2016). Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid Tumors. The Cancer Journal. 22(4). 257–266. 40 indexed citations

16.

Criscione, Steven W., Nicholas Theodosakis, Goran Micevic, et al.. (2016). Genome-wide characterization of human L1 antisense promoter-driven transcripts. BMC Genomics. 17(1). 463–463. 46 indexed citations

17.

Micevic, Goran, Viswanathan Muthusamy, William Damsky, et al.. (2016). DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR. Cell Reports. 14(9). 2180–2192. 60 indexed citations

18.

Theodosakis, Nicholas, Matthew A. Held, Katrina Meeth, et al.. (2015). BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume. Molecular Cancer Therapeutics. 14(7). 1680–1692. 29 indexed citations

19.

Damsky, William, Goran Micevic, Katrina Meeth, et al.. (2015). mTORC1 Activation Blocks BrafV600E-Induced Growth Arrest but Is Insufficient for Melanoma Formation. Cancer Cell. 27(1). 41–56. 87 indexed citations

20.

Ho, Ping‐Chih, Jessica Bihuniak, Andrew N. Macintyre, et al.. (2015). Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses. Cell. 162(6). 1217–1228. 1076 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact